Amyris price target lowered to $1 from $1.50 at Piper Sandler

Piper Sandler analyst Korinne Wolfmeyer lowered the firm’s price target on Amyris to $1 from $1.50 and keeps a Neutral rating on the shares ahead of the Q1 results. The analyst says trade down, China, and travel remain the three key topics to watch this year for the beauty and wellness space. Piper continues to feel most confident in Coty (COTY) and e.l.f. Beauty (ELF) into the quarter, and continues view these two names plus Beauty Health (SKIN) as its top ideas this year.